Learn more

TAIHO PHARMACEUTICAL CO LTD

Overview
  • Total Patents
    2,648
  • GoodIP Patent Rank
    1,954
  • Filing trend
    ⇧ 33.0%
About

TAIHO PHARMACEUTICAL CO LTD has a total of 2,648 patent applications. It increased the IP activity by 33.0%. Its first patent ever was published in 1970. It filed its patents most often in Japan, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are HELSINN THERAPEUTICS US INC, OTHERA HOLDING INC and ALTIRIS THERAPEUTICS.

Patent filings per year

Chart showing TAIHO PHARMACEUTICAL CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Ogawa Kazuo 164
#2 Asao Tetsuji 130
#3 Tanaka Motoaki 112
#4 Yasumoto Sanji 105
#5 Fukushima Masakazu 103
#6 Takeda Setsuo 96
#7 Hashimoto Sadao 89
#8 Yamada Yuji 87
#9 Yasumoto Mitsugi 86
#10 Kajitani Makoto 86

Latest patents

Publication Filing date Title
WO2020256096A1 Method for treating malignant tumor
WO2020255978A1 Novel phosphate ester compound having pyrrolopyrimidine skeleton or pharmaceutically acceptable salt thereof
WO2020241749A1 Combination cancer therapy using sulfonamide compound and immunomodulatory
WO2020175704A1 Cancer therapy using 3,5-disubstituted benzene alkynyl compound and immune checkpoint inhibitor
TW202045509A 7h-pyrrolo[2,3-d]pyrimidine-4-amine derivative
US2020157066A1 Sulfonamide compound or salt thereof
WO2020145374A1 Pyrimidine compound or salt thereof
TW202038965A L718 and/or l792 mutant treatment-resistant egfr inhibitor
TW202038962A Therapeutic and prophylactic method for tumor treatable with endocrine therapy by combined use of fibroblast growth factor receptor inhibitor with endocrine therapy
WO2020096050A1 Dimethoxybenzene compound analogs, methods for analyzing said compounds and standard products of said compounds
TW202033181A Emulsion preparation and preparation method thereof
WO2020085504A1 Method for producing chloroazole carboxylate derivative using sandmeyer reaction with light irradiation
AU2019342447A1 Combination therapy of acylthiourea compound and abiraterone
WO2020045475A1 Crystal of pyrazolo[3,4-d]pyrimidine
TW202023564A Therapeutic agent containing pyrazolo[3,4-d]pyrimidine compound as active ingredient
WO2021024393A1 Cancer combination therapy using azabicyclic compound and polyadenosine-5'-diphosphate ribose polymerase inhibitor
AU2019309987A1 Heterobicyclic compounds for inhibiting the activity of shp2
KR20210024601A Anti-neoplastic drugs and their evaluation methods
US2019350932A1 Preparation and composition for treatment of malignant tumors
TW202015680A Antitumor agent and method for tumor therapy